{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glycogen-storage-disease-due-to-acid-maltase-deficiency-late-onset","columns":[{"gene":"","key":"population-422eae48b51a8b8d196b","label":"Pompe disease, late-onset","mondoId":"MONDO:0018485","onsetQualifier":null,"originColumnKey":"MONDO:0018485/OMIM:621314","originalViews":[{"key":"MONDO:0018485/OMIM:621314","label":"Pompe disease, late-onset","scopeLabel":"OMIM:621314","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["07f4cba977db04a2345349e0d080a345cf0054dbf06179b157227ff791d3da7d","08ab35936df17d9588a12cd3b12a385db422e3c31d26491d2aaa6bfbcdd91cfa","14809c88b4b9c2dde956cbe31c08aa083af67a55c75a8dff46bbf85105bc7269","1496dca6732a10833f8752d1f7d10958acb2e54b64f41369eb14f255847f0786","1755c43dc7ac9b724e255d8a079002d7f03903bd1584e0fee03d3ea48f4e99c0","1f1b09f7049b3ce31dddea4db3be6fd2556e45d48e086c671b1e900932b9aa45","4e554728784f812bc9d84ed3ee06cd2e99b71bdc43dd019027efa3557427f57d","7cfd04c37b8ec846292d0e3b80f9522da417de6ec028fec2aa695e540330aca1","ba4d4a87f53bd6a49744b110219b488e67753a686e93af28e5268fee09690f19","d4a1e6a6c37112a2e548342fdc6bbe6c4e1fc648cbf7e07c1ea5ea2dcdb1ce6b","dd56bb5c4ba3c991a440be6b073c2b1b8f78efd373599fafe20f62aec96602bb","ecf9525190026358fe10663ea94e6a9ef5d11544839787a82fc097471d03c433"],"recordQualifiers":{},"scopeLabel":"OMIM:621314","sourceIds":["OMIM:621314"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-422eae48b51a8b8d196b"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001640","HP:0001638","HP:0003551","HP:0031964","HP:0031956","HP:0003236","HP:0012378"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":12,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"published":12}},"features":[{"hpoId":"HP:0001640","label":"Cardiomegaly","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":true},{"hpoId":"HP:0003551","label":"Difficulty climbing stairs","primary":true},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":true},{"hpoId":"HP:0031956","label":"Elevated circulating aspartate aminotransferase concentration","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0012378","label":"Fatigue","primary":true},{"hpoId":"HP:0003324","label":"Generalized muscle weakness","primary":false},{"hpoId":"HP:0007340","label":"Lower limb muscle weakness","primary":false},{"hpoId":"HP:0012497","label":"Reduced maximal expiratory pressure","primary":false},{"hpoId":"HP:0012496","label":"Reduced maximal inspiratory pressure","primary":false},{"hpoId":"HP:0002098","label":"Respiratory distress","primary":false}],"ledeHtml":"Glycogen storage disease due to acid maltase deficiency, late onset (AMDL), a form of Glycogen storage disease due to acid maltase deficiency (AMD), a degenerative metabolic myopathy particularly affecting respiratory and skeletal muscles, is characterized by an accumulation of glycogen in lysosomes.","mondoId":"MONDO:0018485","node":{"canonicalSlug":"glycogen-storage-disease-due-to-acid-maltase-deficiency-late-onset","comparisons":[{"documentSha256":"bbdc7dbcb1125241fabf64b4acf5377216993e30dba9c5222740e53c97cc67a4","key":"legacy-familial-restrictive-cardiomyopathy","kind":"legacy","label":"familial restrictive cardiomyopathy","memberIds":["MONDO:0007171","MONDO:0007270","MONDO:0009290","MONDO:0012900","MONDO:0014100","MONDO:0014329","MONDO:0014883","MONDO:0015281","MONDO:0016340","MONDO:0017694","MONDO:0018485","MONDO:0030330"],"mondoId":"MONDO:0016340","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/familial-restrictive-cardiomyopathy.bbdc7dbcb1125241fabf64b4acf5377216993e30dba9c5222740e53c97cc67a4.json"},{"documentSha256":"9ab5a6b9360d0e4b301250682497535f4f493f03a5ae6af85956411121f85ec9","key":"expanded-familial-restrictive-cardiomyopathy","kind":"expanded","label":"familial restrictive cardiomyopathy","memberIds":["MONDO:0007171","MONDO:0007270","MONDO:0009265","MONDO:0009290","MONDO:0011895","MONDO:0012306","MONDO:0012900","MONDO:0014100","MONDO:0014329","MONDO:0014883","MONDO:0015281","MONDO:0016340","MONDO:0017694","MONDO:0018485","MONDO:0019122","MONDO:0019441","MONDO:0030330"],"mondoId":"MONDO:0016340","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-9ab5a6b9360d0e4b3012.9ab5a6b9360d0e4b301250682497535f4f493f03a5ae6af85956411121f85ec9.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"glycogen storage disease due to acid maltase deficiency, late-onset","paragraphs":["Glycogen storage disease due to acid maltase deficiency, late onset (AMDL), a form of Glycogen storage disease due to acid maltase deficiency (AMD), a degenerative metabolic myopathy particularly affecting respiratory and skeletal muscles, is characterized by an accumulation of glycogen in lysosomes."],"scope":"exact","source":"MONDO","upstream":"Orphanet:420429","url":"https://monarchinitiative.org/MONDO:0018485"},"ownColumnKeys":["population-422eae48b51a8b8d196b"],"publication":"published","relationships":[{"kind":"parent","label":"glycogen storage disease II","mondoId":"MONDO:0009290","slug":"glycogen-storage-disease-ii"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/21746"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"07f4cba977db04a2345349e0d080a345cf0054dbf06179b157227ff791d3da7d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0001638","is_excluded":true,"label":"Cardiomyopathy","onset_id":null,"reference":"PMID:7668832","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"08ab35936df17d9588a12cd3b12a385db422e3c31d26491d2aaa6bfbcdd91cfa","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"PMID:16917947","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"14809c88b4b9c2dde956cbe31c08aa083af67a55c75a8dff46bbf85105bc7269","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0003324","is_excluded":false,"label":"Generalized muscle weakness","onset_id":null,"reference":"PMID:16917947","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1496dca6732a10833f8752d1f7d10958acb2e54b64f41369eb14f255847f0786","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0012497","is_excluded":false,"label":"Reduced maximal expiratory pressure","onset_id":null,"reference":"PMID:7668832","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1755c43dc7ac9b724e255d8a079002d7f03903bd1584e0fee03d3ea48f4e99c0","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0001640","is_excluded":true,"label":"Cardiomegaly","onset_id":null,"reference":"PMID:7668832","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1f1b09f7049b3ce31dddea4db3be6fd2556e45d48e086c671b1e900932b9aa45","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"8/8","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:16917947;PMID:7668832","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4e554728784f812bc9d84ed3ee06cd2e99b71bdc43dd019027efa3557427f57d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"PMID:16917947","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7cfd04c37b8ec846292d0e3b80f9522da417de6ec028fec2aa695e540330aca1","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0012496","is_excluded":false,"label":"Reduced maximal inspiratory pressure","onset_id":null,"reference":"PMID:7668832","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ba4d4a87f53bd6a49744b110219b488e67753a686e93af28e5268fee09690f19","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003551","is_excluded":false,"label":"Difficulty climbing stairs","onset_id":null,"reference":"PMID:16917947","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d4a1e6a6c37112a2e548342fdc6bbe6c4e1fc648cbf7e07c1ea5ea2dcdb1ce6b","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"4/5","hpo_id":"HP:0002098","is_excluded":false,"label":"Respiratory distress","onset_id":null,"reference":"PMID:16917947","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"dd56bb5c4ba3c991a440be6b073c2b1b8f78efd373599fafe20f62aec96602bb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0031956","is_excluded":false,"label":"Elevated circulating aspartate aminotransferase concentration","onset_id":null,"reference":"PMID:16917947","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ecf9525190026358fe10663ea94e6a9ef5d11544839787a82fc097471d03c433","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:621314","disease_name":"Pompe disease, late-onset","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0007340","is_excluded":false,"label":"Lower limb muscle weakness","onset_id":null,"reference":"PMID:16917947","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018485\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:420429</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Glycogen storage disease due to acid maltase deficiency, late onset (AMDL), a form of Glycogen storage disease due to acid maltase deficiency (AMD), a degenerative metabolic myopathy particularly affecting respiratory and skeletal muscles, is characterized by an accumulation of glycogen in lysosomes.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018485\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"glycogen-storage-disease-due-to-acid-maltase-deficiency-late-onset","sourceDocuments":[{"name":"MONDO: glycogen storage disease due to acid maltase deficiency, late-onset","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018485"}],"sourceNote":"","synonyms":["Alpha-1,4-glucosidase acid deficiency, late onset","Alpha-1,4-glucosidase acid deficiency, late-onset","glycogen storage disease type 2, late onset","glycogen storage disease type 2, late-onset","glycogen storage disease type II, late onset","glycogen storage disease type II, late-onset","glycogenosis type 2, late onset","glycogenosis type 2, late-onset","glycogenosis type II, late onset","glycogenosis type II, late-onset","GSD due to acid maltase deficiency, late onset","GSD due to acid maltase deficiency, late-onset","GSD type 2, late onset","GSD type 2, late-onset","GSD type II, late onset","GSD type II, late-onset","LOPD","Pompe disease, late onset","Pompe disease, late-onset"],"takeawayHtml":"","title":"glycogen storage disease due to acid maltase deficiency, late-onset"},"schemaVersion":1}
